Figure S1 from Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin Plus Docetaxel
Priyanka Sharma,Sara López-Tarruella,José Angel García-Saenz,Qamar J. Khan,Henry L. Gómez,Aleix Prat,Fernando Moreno, Yolanda Jerez-Gilarranz,Agustí Barnadas,Antoni C. Picornell,María del Monte-Millán,Milagros González-Rivera,Tatiana Massarrah,Beatriz Pelaez-Lorenzo,María Isabel Palomero,Ricardo González del Val,Javier Cortés,Hugo Fuentes-Rivera,Denisse Bretel Morales,Iván Márquez-Rodas,Charles M. Perou,Carolyn Lehn,Yen Y. Wang,Jennifer R. Klemp,Joshua V. Mammen,Jamie L. Wagner,Amanda L. Amin,Anne P. O’Dea,Jaimie Heldstab,Roy A. Jensen,Bruce F. Kimler,Andrew K. Godwin,Miguel Martín crossref（2023）
摘要
Pathological response to carboplatin plus docetaxel by germline BRCA status
更多查看译文
关键词
Breast Cancer,cancer susceptibility
AI 理解论文
溯源树
样例
